Literature DB >> 5397406

[HB 419 (Glybenclamide) in the treatment of diabetes mellitus].

I Singh, M C Srivastava.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5397406     DOI: 10.1007/bf01548051

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


× No keyword cloud information.
  17 in total

1.  REVERSAL OF RETINAL VASCULAR CHANGES IN DIABETES.

Authors:  C T DOLLERY; N W OAKLEY
Journal:  Diabetes       Date:  1965-03       Impact factor: 9.461

2.  Diabetic amyotrophy.

Authors:  H GARLAND
Journal:  Br Med J       Date:  1955-11-26

3.  Are diabetic degenerative complications preventable?

Authors:  D M DUNLOP
Journal:  Br Med J       Date:  1954-08-14

4.  Importance of control of diabetes in prevention of vascular complications.

Authors:  N R KEIDING; H F ROOT; A MARBLE
Journal:  J Am Med Assoc       Date:  1952-11-08

5.  Controlled versus free diet management of diabetes.

Authors:  J L WILSON; H F ROOT; A MARBLE
Journal:  J Am Med Assoc       Date:  1951-12-15

6.  Diabetic nephropathy; a clinical syndrome.

Authors:  J L WILSON; H F ROOT; A MARBLE
Journal:  N Engl J Med       Date:  1951-10-04       Impact factor: 91.245

7.  The treatment of diabetes mellitus in infancy and childhood.

Authors:  H WHITTAKER
Journal:  Practitioner       Date:  1949-11

8.  Factors in the rate of development of vascular lesions in the kidneys, retinae and peripheral vessels of the youthful diabetic.

Authors:  H F ROOT; R H SINDEN; R ZANCA
Journal:  Am J Dig Dis       Date:  1950-06

9.  Incidence of diabetic retinopathy relative to the degree of diabetic control.

Authors:  S SPOONT; W W DYER; R DAY; H BLAZER
Journal:  Am J Med Sci       Date:  1951-05       Impact factor: 2.378

10.  Modification of response to the triamcinolone glucose tolerance test by treatment with oral hypoglycemic agents.

Authors:  V N Navarrete; I H Torres; L Castelazo Ayala; C R Alger; H V Flores
Journal:  Diabetes       Date:  1966-10       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.